The sex-specific associations of the aromatase gene with Alzheimer’s disease and its interaction with IL10 in the Epistasis Project
暂无分享,去创建一个
P. Deloukas | K. Morgan | K. Brown | A. Smith | P. Kehoe | P. Koudstaal | O. Combarros | I. Mateo | V. Álvarez | M. Ikram | H. Butler | Naomi Hammond | C. Ibrahim-Verbaas | D. Lehmann | D. Warden | C. Medway | E. Coto | R. F. D. Bruijn | H. Kölsch | G. Wilcock | O. Belbin | C. Duijn | R. Heun | M. Cortina-Borja | P. Sánchez-Juan | M. Ikram | R. F. de Bruijn | R. Barber | Michael G. Lehmann | C. V. van Duijn | Naomi Hammond
[1] C. Pike,et al. Gender, sex steroid hormones, and Alzheimer's disease , 2013, Hormones and Behavior.
[2] M. Velders,et al. Selective estrogen receptor‐β activation stimulates skeletal muscle growth and regeneration , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[3] P. Deloukas,et al. Interaction of insulin and PPAR-α genes in Alzheimer’s disease: the Epistasis Project , 2012, Journal of Neural Transmission.
[4] K. Jin,et al. Estrogen, neuroprotection and neurogenesis after ischemic stroke. , 2012, Current drug targets.
[5] E. Mufson,et al. Effects of aromatase inhibition versus gonadectomy on hippocampal complex amyloid pathology in triple transgenic mice , 2012, Neurobiology of Disease.
[6] P. Ascenzi,et al. Neuroprotective Effects of 17β-Estradiol Rely on Estrogen Receptor Membrane Initiated Signals , 2012, Front. Physio..
[7] J. Lewis,et al. A non-synonymous coding change in the CYP19A1 gene Arg264Cys (rs700519) does not affect circulating estradiol, bone structure or fracture , 2011, BMC Medical Genetics.
[8] L. Garcia-Segura,et al. Neuroprotective actions of estradiol revisited , 2011, Trends in Endocrinology & Metabolism.
[9] S. D. de Medeiros,et al. Cellular and humoral immune responses after short-term oral hormone therapy in postmenopausal women , 2011, Climacteric : the journal of the International Menopause Society.
[10] Manolis Kellis,et al. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants , 2011, Nucleic Acids Res..
[11] D. Swaab,et al. Neurosteroid biosynthetic pathways changes in prefrontal cortex in Alzheimer's disease , 2011, Neurobiology of Aging.
[12] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.
[13] S. Yamawaki,et al. Protective Action of Neurotrophic Factors and Estrogen against Oxidative Stress-Mediated Neurodegeneration , 2011, Journal of toxicology.
[14] J Zhang,et al. The −1082G/A polymorphism in IL-10 gene is associated with risk of Alzheimer's disease: A meta-analysis , 2011, Journal of the Neurological Sciences.
[15] C. Pike,et al. Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease , 2011, Neurobiology of Aging.
[16] D. Altshuler,et al. A map of human genome variation from population-scale sequencing , 2010, Nature.
[17] P. Wise,et al. Production of proinflammatory cytokines and chemokines during neuroinflammation: novel roles for estrogen receptors alpha and beta. , 2010, Endocrinology.
[18] Hideo Mukai,et al. Modulation of synaptic plasticity by brain estrogen in the hippocampus. , 2010, Biochimica et biophysica acta.
[19] F. Sohrabji,et al. Reproductive age modulates the impact of focal ischemia on the forebrain as well as the effects of estrogen treatment in female rats , 2010, Neurobiology of Aging.
[20] G. Gillies,et al. Estrogen Actions in the Brain and the Basis for Differential Action in Men and Women: A Case for Sex-Specific Medicines , 2010, Pharmacological Reviews.
[21] F. Sohrabji,et al. The Neurotoxic Effects of Estrogen on Ischemic Stroke in Older Female Rats Is Associated with Age-Dependent Loss of Insulin-Like Growth Factor-1 , 2010, The Journal of Neuroscience.
[22] P. Guyre,et al. Estradiol Suppresses NF-κB Activation through Coordinated Regulation of let-7a and miR-125b in Primary Human Macrophages , 2010, The Journal of Immunology.
[23] H. Offner,et al. GPR30, but not estrogen receptor-α, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiol , 2010, BMC Immunology.
[24] J. Ragoussis,et al. Association of the aromatase gene with Alzheimer's disease in women , 2010, Neuroscience Letters.
[25] Mario Cortina-Borja,et al. Open Access Journal of Neuroinflammation Replication by the Epistasis Project of the Interaction between the Genes for Il-6 and Il-10 in the Risk of Alzheimer's Disease , 2022 .
[26] G. Moretto,et al. Genetic Variation of CYP19 (Aromatase) Gene Influences Age at Onset of Alzheimer’s Disease in Women , 2009, Dementia and Geriatric Cognitive Disorders.
[27] Andrew D. Johnson,et al. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap , 2008, Bioinform..
[28] Roberta Diaz Brinton,et al. Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer's disease. , 2008, Advanced drug delivery reviews.
[29] R. Brinton,et al. The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications , 2008, Trends in Neurosciences.
[30] H. A. Harris,et al. Selective estrogen receptor-β agonists repress transcription of proinflammatory genes , 2008, The Journal of Immunology.
[31] J. Simpkins,et al. Mitochondrial mechanisms of estrogen neuroprotection , 2008, Brain Research Reviews.
[32] O. Combarros,et al. Aromatase and interleukin-10 genetic variants interactively modulate Alzheimer’s disease risk , 2008, Journal of Neural Transmission.
[33] D. Tatomer,et al. Selective Estrogen Receptor-β Agonists Repress Transcription of Proinflammatory Genes1 , 2008, The Journal of Immunology.
[34] F. Morón,et al. Sex and Body Mass Index Specific Regulation of Blood Pressure by CYP19A1 Gene Variants , 2007, Hypertension.
[35] I. Loy-English,et al. Gender differences in dementia risk factors. , 2007, Gender medicine.
[36] S. Sorbi,et al. Association of IL10 promoter polymorphism in Italian Alzheimer's disease , 2007, Neuroscience Letters.
[37] D. Brann,et al. Neurotrophic and neuroprotective actions of estrogen: Basic mechanisms and clinical implications , 2007, Steroids.
[38] D. Altshuler,et al. Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. , 2007, Cancer research.
[39] J. DeFelipe,et al. Aromatase expression in the human temporal cortex , 2006, Neuroscience.
[40] Tony Wyss-Coray,et al. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? , 2006, Nature Medicine.
[41] S. Poduslo,et al. CYP19 haplotypes increase risk for Alzheimer’s disease , 2006, Journal of Medical Genetics.
[42] L. K. Marriott,et al. Multiple pathways transmit neuroprotective effects of gonadal steroids , 2006, Endocrine.
[43] A. Członkowska,et al. Gender differences in neurological disease , 2006, Endocrine.
[44] Rena Li,et al. Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[45] O. Combarros,et al. Interaction between CYP19 Aromatase and Butyrylcholinesterase Genes Increases Alzheimer’s Disease Risk , 2005, Dementia and Geriatric Cognitive Disorders.
[46] C. Brayne,et al. The Incidence of Dementia in England and Wales: Findings from the Five Identical Sites of the MRC CFA Study , 2005, PLoS medicine.
[47] H. Chiu,et al. The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease , 2005, Neurobiology of Aging.
[48] A. Bruce-Keller,et al. Estrogen and brain inflammation: Effects on microglial expression of MHC, costimulatory molecules and cytokines , 2005, Journal of Neuroimmunology.
[49] D. Murphy,et al. The Women's Health Initiative Memory Study: findings and implications for treatment , 2005, The Lancet Neurology.
[50] E. Hol,et al. Diminished aromatase immunoreactivity in the hypothalamus, but not in the basal forebrain nuclei in Alzheimer’s disease , 2005, Neurobiology of Aging.
[51] B. Ponder,et al. Polymorphisms associated with circulating sex hormone levels in postmenopausal women. , 2005, Journal of the National Cancer Institute.
[52] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[53] D. Giordano,et al. 17-ß-estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells Short title: The effect of 17-ß-estradiol on dendritic cells , 2004 .
[54] Ivan Ovcharenko,et al. ECR Browser: a tool for visualizing and accessing data from comparisons of multiple vertebrate genomes , 2004, Nucleic Acids Res..
[55] Michael Frotscher,et al. Hippocampal Synapses Depend on Hippocampal Estrogen Synthesis , 2004, The Journal of Neuroscience.
[56] P. Kramer,et al. 17β‐estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte‐derived macrophages , 2004 .
[57] E. Corder,et al. Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease , 2004, Neurology.
[58] E. Hogervorst,et al. The Controversy Over Levels of Sex Steroids in Cases with Alzheimer's Disease , 2004, Journal of neuroendocrinology.
[59] C. Ulrich,et al. Association of CYP17, CYP19, CYP1B1, and COMT Polymorphisms with Serum and Urinary Sex Hormone Concentrations in Postmenopausal Women , 2004, Cancer Epidemiology Biomarkers & Prevention.
[60] B. Stoffel‐Wagner. Neurosteroid Biosynthesis in the Human Brain and Its Clinical Implications , 2003, Annals of the New York Academy of Sciences.
[61] L. Garcia-Segura,et al. Aromatase Expression by Reactive Astroglia Is Neuroprotective , 2003, Annals of the New York Academy of Sciences.
[62] Arto Mannermaa,et al. Apolipoprotein E 4 Allele, Elevated Midlife Total Cholesterol Level, and High Midlife Systolic Blood Pressure Are Independent Risk Factors for Late-Life Alzheimer Disease , 2002, Annals of Internal Medicine.
[63] Rena Li,et al. Effects of estrogen treatment on glutamate uptake in cultured human astrocytes derived from cortex of Alzheimer's disease patients , 2002, Journal of neurochemistry.
[64] F. Ross,et al. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. , 1999, The Journal of clinical investigation.
[65] D Commenges,et al. Are sex and educational level independent predictors of dementia and Alzheimer’s disease? Incidence data from the PAQUID project , 1999, Journal of neurology, neurosurgery, and psychiatry.
[66] A. Hofman,et al. Incidence and risk of dementia. The Rotterdam Study. , 1998, American journal of epidemiology.
[67] M. Lazarus,et al. An investigation of polymorphism in the interleukin-10 gene promoter. , 1997, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[68] B. Winblad,et al. Very Old Women at Highest Risk of Dementia and Alzheimer's Disease , 1997, Neurology.
[69] R. D'Agostino,et al. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. , 1993, American journal of epidemiology.
[70] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.
[71] C. Caruso,et al. Association between interleukin-10 polymorphisms and Alzheimer's disease: a systematic review and meta-analysis. , 2012, Journal of Alzheimer's disease : JAD.
[72] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[73] Mario Cortina-Borja,et al. The synergy factor: a statistic to measure interactions in complex diseases , 2009, BMC Research Notes.
[74] R. Brinton,et al. Estradiol-17beta-induced human neural progenitor cell proliferation is mediated by an estrogen receptor beta-phosphorylated extracellularly regulated kinase pathway. , 2008, Endocrinology.
[75] D. Swaab,et al. Estrogen receptor alpha and its splice variants in the hippocampus in aging and Alzheimer's disease. , 2007, Neurobiology of aging.
[76] P. Lønning,et al. Genetic variants of CYP19 (aromatase) and breast cancer risk , 2000, Oncogene.